Works matching AU Makris, M.

Results: 171

Recombinant factor VIIa for unlicensed indications--a definite No or a cautious Maybe in selected patients?
Published in:
2010
By:
- Sorour Y;
- van Veen JJ;
- Makris M;
- Sorour, Y;
- Van Veen, J J;
- Makris, M
Publication type:
Editorial
MECHANISTIC ENZYMOLOGY OF OXYGEN ACTIVATION BY THE CYTOCHROMES P450.
Published in:
Drug Metabolism Reviews, 2002, v. 34, n. 4, p. 691, doi. 10.1081/DMR-120015691
By:
- Makris, Thomas M.;
- Davydov, Roman;
- Denisov, Ilia G.;
- Hoffman, Brian M.;
- Sligar, Stephen G.
Publication type:
Article
Treatment of bleeding episodes in haemophilia A complicated by a factor VIII inhibitor in patients receiving Emicizumab. Interim guidance from UKHCDO Inhibitor Working Party and Executive Committee.
Published in:
Haemophilia, 2018, v. 24, n. 3, p. 344, doi. 10.1111/hae.13495
By:
- Collins, P. W.;
- Hart, D. P.;
- Liesner, R.;
- Makris, M.;
- Talks, K.;
- Chowdary, P.;
- Riddell, A.;
- Chalmers, E.;
- Hall, G.;
- Percy, C. L.;
- Hay, C. R.
Publication type:
Article
A golden age for Haemophilia treatment?
Published in:
2018
By:
- Makris, M.;
- Hermans, C.
Publication type:
Editorial
Pharmacokinetics, safety and efficacy of a recombinant factor IX product, trenonacog alfa in previously treated haemophilia B patients.
Published in:
Haemophilia, 2018, v. 24, n. 1, p. 104, doi. 10.1111/hae.13324
By:
- Collins, P. W.;
- Babinchak, T. J.;
- Gomperts, E. D.;
- Quon, D. V. K.;
- Makris, M.;
- Chowdary, P.;
- Kempton, C. L.;
- Apte, S. J.;
- Ramanan, M. V.;
- Hay, C. R. M.;
- Drobic, B.;
- Hua, Y.
Publication type:
Article
Haemophilia of the third age.
Published in:
Haemophilia, 2018, v. 24, n. 1, p. 15, doi. 10.1111/hae.13257
By:
- Harrison, C.;
- Saccullo, G.;
- Makris, M.
Publication type:
Article
The coagulation laboratory monitoring of Afstyla single-chain FVIII concentrate.
Published in:
Haemophilia, 2017, v. 23, n. 5, p. e469, doi. 10.1111/hae.13290
By:
- Bowyer, A.;
- Key, N.;
- Dalton, D.;
- Kitchen, S.;
- Makris, M.
Publication type:
Article
First-line immune tolerance induction for children with severe haemophilia A: A protocol from the UK Haemophilia Centre Doctors' Organisation Inhibitor and Paediatric Working Parties.
Published in:
Haemophilia, 2017, v. 23, n. 5, p. 654, doi. 10.1111/hae.13264
By:
- Collins, P.;
- Chalmers, E.;
- Alamelu, J.;
- Hay, C.;
- Liesner, R.;
- Makris, M.;
- Mathias, M.;
- Payne, J.;
- Rangarajan, S.;
- Richards, M.;
- Talks, K.;
- Tunstall, O.;
- Williams, M.;
- Hart, D. P.
Publication type:
Article
von Willebrand disease and extra-intestinal angiodysplasia.
Published in:
Haemophilia, 2017, v. 23, n. 4, p. e354, doi. 10.1111/hae.13204
By:
- Vulpen, L. F. D.;
- Keeling, D.;
- Makris, M.
Publication type:
Article
SIPPET trial: the answers.
Published in:
2017
By:
- Makris, M.;
- Kessler, C. M.
Publication type:
Editorial
Hepatitis C in haemophilia: time for treatment for all.
Published in:
2017
By:
- Makris, M.;
- Konkle, B. A.
Publication type:
Editorial
Natural history and clinical characteristics of inhibitors in previously treated haemophilia A patients: a case series.
Published in:
Haemophilia, 2017, v. 23, n. 2, p. 255, doi. 10.1111/hae.13167
By:
- Iorio, A.;
- Barbara, A. M.;
- Makris, M.;
- Fischer, K.;
- Castaman, G.;
- Catarino, C.;
- Gilman, E.;
- Kavakli, K.;
- Lambert, T.;
- Lassila, R.;
- Lissitchkov, T.;
- Mauser‐Bunschoten, E.;
- Mingot‐Castellano, M. E.;
- Ozdemir, N.;
- Pabinger, I.;
- Parra, R.;
- Pasi, J.;
- Peerlinck, K.;
- Rauch, A.;
- Roussel‐Robert, V.
Publication type:
Article
New Findings on Inhibitor Development: from Registries to Clinical Studies.
Published in:
Haemophilia, 2017, v. 23, p. 4, doi. 10.1111/hae.13137
By:
- PEYVANDI, F.;
- ETTINGSHAUSEN, C. E.;
- GOUDEMAND, J.;
- JIMÉNEZ-YUSTE, V.;
- SANTAGOSTINO, E.;
- MAKRIS, M.
Publication type:
Article
Inhibitor development in haemophilia.
Published in:
Haemophilia, 2017, v. 23, p. 3, doi. 10.1111/hae.13145
By:
- Peyvandi, F.;
- Makris, M.
Publication type:
Article
Factor VIII assay variability in postinfusion samples containing full length and B-domain deleted FVIII.
Published in:
Haemophilia, 2016, v. 22, n. 5, p. 806, doi. 10.1111/hae.12962
By:
- Kitchen, S.;
- Jennings, I.;
- Makris, M.;
- Kitchen, D. P.;
- Woods, T. A. L.;
- Walker, I. D.
Publication type:
Article
NHF-McMaster Guideline on Care Models for Haemophilia Management.
Published in:
Haemophilia, 2016, v. 22, p. 6, doi. 10.1111/hae.13008
By:
- Pai, M.;
- Key, N. S.;
- Skinner, M.;
- Curtis, R.;
- Feinstein, M.;
- Kessler, C.;
- Lane, S. J.;
- Makris, M.;
- Riker, E.;
- Santesso, N.;
- Soucie, J. M.;
- Yeung, C. H. T.;
- Iorio, A.;
- Schünemann, H. J.
Publication type:
Article
Care models in the management of haemophilia: a systematic review.
Published in:
Haemophilia, 2016, v. 22, p. 31, doi. 10.1111/hae.13000
By:
- Yeung, C. H. T.;
- Santesso, N.;
- Pai, M.;
- Kessler, C.;
- Key, N. S.;
- Makris, M.;
- Navarro‐Ruan, T.;
- Soucie, J. M.;
- Schünemann, H. J.;
- Iorio, A.
Publication type:
Article
Congenital macrothrombocytopenia is a heterogeneous disorder in India.
Published in:
Haemophilia, 2016, v. 22, n. 4, p. 570, doi. 10.1111/hae.12917
By:
- Ali, S.;
- Ghosh, K.;
- Daly, M. E.;
- Hampshire, D. J.;
- Makris, M.;
- Ghosh, M.;
- Mukherjee, L.;
- Bhattacharya, M.;
- Shetty, S.
Publication type:
Article
Choosing and using non-steroidal anti-inflammatory drugs in haemophilia.
Published in:
Haemophilia, 2016, v. 22, n. 2, p. 179, doi. 10.1111/hae.12805
By:
- Arachchillage, D. R. J.;
- Makris, M.
Publication type:
Article
Von Willebrand factor activity assay errors.
Published in:
Haemophilia, 2016, v. 22, n. 1, p. e74, doi. 10.1111/hae.12862
By:
- Bowyer, A. E.;
- Guy, S.;
- Shepherd, M. F.;
- Sampson, B. M.;
- Kitchen, S.;
- Makris, M.
Publication type:
Article
FVIII inhibitor development according to concentrate: data from the EUHASS registry excluding overlap with other studies.
Published in:
Haemophilia, 2016, v. 22, n. 1, p. e36, doi. 10.1111/hae.12764
By:
- Fischer, K.;
- Iorio, A.;
- Hollingsworth, R.;
- Makris, M.;
- Watson, Henry;
- Rae, Joan;
- Platokouki, Helen;
- Pergantou, Helen;
- Katsarou, Olga;
- Theodossiades, George;
- Nomikou, Efrosyni;
- Parra, Rafael;
- Alonso, Sofia;
- Klamroth, Robert;
- Kubicek, Cornelia;
- Wilde, Jonathan;
- Dunkley, Tracey;
- Oldenburg, Johannes;
- Schmickler, Daniela;
- Ackroyd, Sam
Publication type:
Article
The natural history of occult or angiodysplastic gastrointestinal bleeding in von Willebrand disease.
Published in:
Haemophilia, 2015, v. 21, n. 3, p. 338, doi. 10.1111/hae.12571
By:
- Makris, M.;
- Federici, A. B.;
- Mannucci, P. M.;
- Bolton‐Maggs, P. H. B.;
- Yee, T. T.;
- Abshire, T.;
- Berntorp, E.
Publication type:
Article
FXI concentrate use and risk of thrombosis.
Published in:
Haemophilia, 2014, v. 20, n. 4, p. e349, doi. 10.1111/hae.12457
By:
- Bolton‐Maggs, P.;
- Goudemand, J.;
- Hermans, C.;
- Makris, M.;
- Moerloose, P.
Publication type:
Article
Major surgery in severe haemophilia A with inhibitors using a recombinant factor VIIa and activated prothrombin complex concentrate hybrid regimen.
Published in:
Haemophilia, 2014, v. 20, n. 4, p. 587, doi. 10.1111/hae.12365
By:
- VAN VEEN, J. J.;
- MACLEAN, R. M.;
- HAMPTON, K. K.;
- HAMER, A.;
- MAKRIS, M.
Publication type:
Article
Enhancing haemophilia care through registries.
Published in:
Haemophilia, 2014, v. 20, p. 121, doi. 10.1111/hae.12406
By:
- DOLAN, G.;
- MAKRIS, M.;
- BOLTON-MAGGS, P. H. B.;
- ROWELL, J. A.
Publication type:
Article
Enhancing haemophilia care through registries.
Published in:
Haemophilia, 2014, v. 20, p. 121, doi. 10.1111/hae.12406
By:
- Dolan, G.;
- Makris, M.;
- Bolton-Maggs, P. H. B.;
- Rowell, J. A.
Publication type:
Article
Assaying FVIII activity: one method is not enough, and never was.
Published in:
2014
By:
- Makris, M.;
- Peyvandi, F.
Publication type:
Editorial
Switching clotting factor concentrates: considerations in estimating the risk of immunogenicity.
Published in:
Haemophilia, 2014, v. 20, n. 2, p. 200, doi. 10.1111/hae.12283
By:
- Matino, D.;
- Lillicrap, D.;
- Astermark, J.;
- Dolan, G.;
- Kessler, C.;
- Lambert, T.;
- Makris, M.;
- O'Donnell, J.;
- Pipe, S.;
- Santagostino, E.;
- Saint‐Remy, J.‐M.;
- Schramm, W.;
- Iorio, A.
Publication type:
Article
Update to UKHCDO guidance on vaccination against hepatitis A and B viruses in patients with inherited coagulation factor deficiencies and von Willebrand disease.
Published in:
Haemophilia, 2013, v. 19, n. 3, p. e191, doi. 10.1111/hae.12139
By:
- Watson, H. G.;
- Wilde, J. T.;
- Dolan, G.;
- Millar, C.;
- Yee, T. T.;
- Makris, M.
Publication type:
Article
Third Åland islands conference on von Willebrand disease, 26-28 September 2012: meeting report.
Published in:
Haemophilia, 2013, v. 19, p. 1, doi. 10.1111/hae.12078
By:
- Berntorp, E.;
- Fuchs, B.;
- Makris, M.;
- Montgomery, R.;
- Flood, V.;
- O'Donnell, J. S.;
- Federici, A. B.;
- Lillicrap, D.;
- James, P.;
- Budde, U.;
- Morfini, M.;
- Petrini, P.;
- Austin, S.;
- Kannicht, C.;
- Jiménez-Yuste, V.;
- Lee, C.
Publication type:
Article
Prophylaxis in severe forms of von Willebrand's disease: results from the von Willebrand Disease Prophylaxis Network (VWD PN).
Published in:
Haemophilia, 2013, v. 19, n. 1, p. 76, doi. 10.1111/j.1365-2516.2012.02916.x
By:
- Abshire, T. C.;
- Federici, A. B.;
- Alvárez, M. T.;
- Bowen, J.;
- Carcao, M. D.;
- Cox Gill, J.;
- Key, N. S.;
- Kouides, P. A.;
- Kurnik, K.;
- Lail, A. E.;
- Leebeek, F. W. G.;
- Makris, M.;
- Mannucci, P. M.;
- Winikoff, R.;
- Berntorp, E.
Publication type:
Article
The World Federation of Hemophilia guideline on management of haemophilia.
Published in:
Haemophilia, 2013, v. 19, n. 1, p. 1, doi. 10.1111/hae.12074
By:
- Makris, M.;
- Kasper, C.
Publication type:
Article
Pharmacokinetic properties of IB1001, an investigational recombinant factor IX, in patients with haemophilia B: repeat pharmacokinetic evaluation and sialylation analysis.
Published in:
Haemophilia, 2012, v. 18, n. 6, p. 881, doi. 10.1111/j.1365-2516.2012.02897.x
By:
- Martinowitz, U.;
- Shapiro, A.;
- Quon, D. V.;
- Escobar, M.;
- Kempton, C.;
- Collins, P. W.;
- Chowdary, P.;
- Makris, M.;
- Mannucci, P. M.;
- Morfini, M.;
- Valentino, L. A.;
- Gomperts, E.;
- Lee, M.
Publication type:
Article
Malignant disease in the haemophilic population: moving towards a management consensus?
Published in:
Haemophilia, 2012, v. 18, n. 5, p. 664, doi. 10.1111/j.1365-2516.2012.02846.x
By:
- Astermark, J.;
- Makris, M.;
- Mauser-Bunschoten, E.;
- Nemes, L.;
- D'oiron, R.;
- Oldenburg, J.;
- Ingerslev, J.
Publication type:
Article
How I treat inhibitors in haemophilia.
Published in:
Haemophilia, 2012, v. 18, p. 48, doi. 10.1111/j.1365-2516.2012.02829.x
By:
- MAKRIS, M.;
- HAY, C. R. M.;
- GRINGERI, A.;
- D'OIRON, R.
Publication type:
Article
A prospective registry of European haemophilia B patients receiving nonacog alfa, recombinant human factor IX, for usual use.
Published in:
Haemophilia, 2012, v. 18, n. 4, p. 503, doi. 10.1111/j.1365-2516.2011.02685.x
By:
- BERNTORP, E.;
- KEELING, D.;
- MAKRIS, M.;
- TAGLIAFERRI, A.;
- MALE, C.;
- MAUSER-BUNSCHOTEN, E. P.;
- MUSSO, R.;
- ROCA, C. A.;
- HASSOUN, A.;
- KOLLMER, C.;
- CHARNIGO, R.;
- BAUMANN, J.;
- RENDO, P.
Publication type:
Article
Management of muscle haematomas in patients with severe haemophilia in an evidence-poor world.
Published in:
Haemophilia, 2012, v. 18, n. 4, p. 598, doi. 10.1111/j.1365-2516.2011.02720.x
By:
- SØRENSEN, B.;
- BENSON, G. M.;
- BLADEN, M.;
- CLASSEY, S.;
- KEELING, D. M.;
- MCLAUGHLIN, P.;
- YEE, T. T.;
- MAKRIS, M.
Publication type:
Article
Thrombotic adverse events to coagulation factor concentrates for treatment of patients with haemophilia and von Willebrand disease: a systematic review of prospective studies.
Published in:
Haemophilia, 2012, v. 18, n. 3, p. e173, doi. 10.1111/j.1365-2516.2012.02758.x
By:
- COPPOLA, A.;
- FRANCHINI, M.;
- MAKRIS, M.;
- SANTAGOSTINO, E.;
- DI MINNO, G.;
- MANNUCCI, P. M.
Publication type:
Article
Non-thrombotic-, non-inhibitor-associated adverse reactions to coagulation factor concentrates for treatment of patients with hemophilia and von Willebrand's disease: a systematic review of prospective studies.
Published in:
Haemophilia, 2012, v. 18, n. 3, p. e164, doi. 10.1111/j.1365-2516.2011.02745.x
By:
- FRANCHINI, M.;
- MAKRIS, M.;
- SANTAGOSTINO, E.;
- COPPOLA, A.;
- MANNUCCI, P. M.
Publication type:
Article
The risk of variant Creutzfeldt-Jakob disease among UK patients with bleeding disorders, known to have received potentially contaminated plasma products.
Published in:
Haemophilia, 2011, v. 17, n. 6, p. 931, doi. 10.1111/j.1365-2516.2011.02508.x
By:
- ZAMAN, S. M. A.;
- HILL, F. G. H.;
- PALMER, B.;
- MILLAR, C. M.;
- BONE, A.;
- MOLESWORTH, A. M.;
- CONNOR, N.;
- LEE, C. A.;
- DOLAN, G.;
- WILDE, J. T.;
- GILL, O. N.;
- MAKRIS, M.
Publication type:
Article
UKHCDO guidelines on the management of HCV in patients with hereditary bleeding disorders 2011.
Published in:
Haemophilia, 2011, v. 17, n. 5, p. e877, doi. 10.1111/j.1365-2516.2011.02585.x
By:
- WILDE, J. T.;
- MUTIMER, D.;
- DOLAN, G.;
- MILLAR, C.;
- WATSON, H. G.;
- YEE, T. T.;
- MAKRIS, M.
Publication type:
Article
Experience with Optivate.
Published in:
Haemophilia, 2011, v. 17, n. 3, p. 428, doi. 10.1111/j.1365-2516.2010.02441.x
By:
- Hay, C. R. M.;
- Hellmann, A.;
- Dmoszynska, A.;
- Baglin, T.;
- O'Shaunessey, D.;
- Makris, M.;
- Shaikh-Zaidi, R.;
- Dash, C. H.
Publication type:
Article
Pharmacokinetics of Optivate.
Published in:
Haemophilia, 2011, v. 17, n. 2, p. 185, doi. 10.1111/j.1365-2516.2010.02414.x
By:
- DMOSZYNSKA, A.;
- HELLMANN, A.;
- BAGLIN, T.;
- O'SHAUGNESSY, D.;
- TRELINSKI, J.;
- KULICZKOWSKI, K.;
- KLOCZKO, J.;
- HAY, C.;
- ZAWILSKA, K.;
- MAKRIS, M.;
- SHAIKH-ZAIDI, R.;
- GASCOIGNE, E.;
- DASH, C.
Publication type:
Article
Clinical assessment of Optivate.
Published in:
Haemophilia, 2011, v. 17, n. 3, p. 456, doi. 10.1111/j.1365-2516.2010.02446.x
By:
- Dmoszynska, A.;
- Kuliczkowski, K.;
- Hellmann, A.;
- Trelinski, J.;
- Kloczko, J.;
- Baglin, T.;
- Hay, C.;
- O'Shaughnessy, D.;
- Zawilska, K.;
- Makris, M.;
- Shaikh-Zaidi, R.;
- Gascoigne, E.;
- Dash, C.
Publication type:
Article
Biovigilance and pharmacovigilance for haemophilia.
Published in:
Haemophilia, 2010, v. 16, p. 17, doi. 10.1111/j.1365-2516.2010.02288.x
By:
- WEINSTEIN, M.;
- MAKRIS, M.;
- LUDLAM, C.A.
Publication type:
Article
Risk reduction strategies for variant Creutzfeldt–Jakob disease transmission by UK plasma products and their impact on patients with inherited bleeding disorders.
Published in:
Haemophilia, 2010, v. 16, n. 2, p. 305, doi. 10.1111/j.1365-2516.2010.02220.x
By:
- MILLAR, C. M.;
- CONNOR, N.;
- DOLAN, G.;
- LEE, C. A.;
- MAKRIS, M.;
- WILDE, J.;
- WINTER, M.;
- IRONSIDE, J. W.;
- GILL, N.;
- HILL, F. G. H.
Publication type:
Article
Guideline on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders.
Published in:
Haemophilia, 2008, v. 14, n. 4, p. 671, doi. 10.1111/j.1365-2516.2008.01695.x
By:
- KEELING, D.;
- TAIT, C.;
- MAKRIS, M.
Publication type:
Article
Paracetamol/acetaminophen usage in haemophilia: more caution needed?
Published in:
Haemophilia, 2008, v. 14, n. 3, p. 434, doi. 10.1111/j.1365-2516.2008.01653.x
By:
- Van Veen, J. J.;
- Gleeson, D. C.;
- Makris, M.
Publication type:
Article
Liver transplantation for factor XI deficiency: cure before diagnosis.
Published in:
2008
By:
- Simpson, E.;
- Gillett, G.;
- Makris, M.
Publication type:
Letter
Haemoperitoneum associated with ovulation in women with bleeding disorders: the case for conservative management and the role of the contraceptive pill.
Published in:
Haemophilia, 2007, v. 13, n. 1, p. 93, doi. 10.1111/j.1365-2516.2006.01399.x
By:
- PAYNE, J. H.;
- MACLEAN, R. M.;
- HAMPTON, K. K.;
- BAXTER, A. J.;
- MAKRIS, M.
Publication type:
Article